Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease. - Wikidata - awgldk - TriplyDB

Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.

Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.

http://www.wikidata.org/entity/Q44144568

about

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management Crohn's disease in women Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)Safety of TNF-α inhibitors during IBD pregnancy: a systematic review Treatment of pregnant women with a diagnosis of inflammatory bowel disease Managing inflammatory bowel disease in pregnancy: current perspectives Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions Pregnancy and Inflammatory Bowel Disease Overcoming challenges of treating inflammatory bowel disease in pregnancy.Use of thiopurines in inflammatory bowel disease: Safety issues.Review article: autoimmune hepatitis -- current management and challenges.Management of the pregnant inflammatory bowel disease patient on anti-tumour necrosis factor: state of the art and future directions.Surgery for Severe Ulcerative Colitis during Pregnancy: Report of Two Cases Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding Varies Widely: A Need for Further Education Proper Use of Inflammatory Bowel Disease Drugs during Pregnancy.From conception to delivery: managing the pregnant inflammatory bowel disease patient.Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease.IBD medications during pregnancy and lactation.Management of fertility and pregnancy in women with inflammatory bowel disease: a practical guide.Management of gastrointestinal and liver diseases during pregnancy.Inflammatory bowel disease in women of reproductive age.Safety of biological therapies for psoriasis: effects on reproductive potential and outcomes in male and female patients.Anti-TNFα therapies are safe during pregnancy in women with inflammatory bowel disease: a systematic review and meta-analysis.Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation.How safe is infliximab therapy during pregnancy and lactation in inflammatory bowel disease?Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.Republished curriculum based clinical review: IBD: reproductive health, pregnancy and lactation.Pregnancy and the Immune System: General Overview and the Gastroenterological Perspective.Treating Psoriasis During Pregnancy: Safety and Efficacy of Treatments.Use of Immunomodulators and Biologics Before, During, and After Pregnancy.Treatment of the Pregnant Patient with Inflammatory Bowel Disease.Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease.Managing IBD Therapies in Pregnancy.Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature.Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era.Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception.Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.Exposure to biologic therapies during conception and pregnancy: a systematic review.

P2860

Q26765038-2E49077D-2404-4C6A-8287-32F34BD5D757 Q26777627-5CEBF755-CADE-41A1-95E7-9E64FE3A5B71 Q26851451-86793E11-3086-45A1-A7AB-35B6CE810D87 Q26996946-E833B9D9-C716-4B15-B4AC-931DE583AC74 Q27008090-DDB33474-3364-4718-A533-1070410BBE1D Q28067821-6EA21E5E-D9C5-454C-A658-5BE17F70E595 Q28068318-9CE8CFA8-7860-4E24-92E2-6C51A1B7A8D6 Q28076505-081240A8-B9A9-4A12-A12F-B488BB0CAE17 Q28392552-B9BB59A0-7A63-41D0-8F4E-E706DA5412BF Q30251775-4669DD8B-828F-4C78-B40F-57D0F8227BC8 Q33621267-BB3ABBF1-D2D5-4D41-A714-2BDFDE7C4886 Q34369116-E1BAF980-6413-40C3-858E-DFED78470B78 Q34385326-5613F20D-A480-4CE9-BD60-789B70097195 Q35540972-CCF6453D-6E38-4C6C-8B8A-7739EE50B00E Q36125487-66B76CDC-417E-4338-98EF-21F2DD952F70 Q37306723-5323B4D8-500A-4450-93F0-FA31D26ED380 Q37656466-A1C75440-4654-4661-88FD-A6BEB4F4E26C Q37682503-33A1A9AE-C5EF-4FA0-BC92-03445FFAC9A2 Q38113455-2BAF685D-F205-4278-989B-604272EC0DDE Q38125114-B2E445BE-2381-449B-8643-112DFEB83FBA Q38128948-061E8AFF-717B-49C9-BF3E-3D547A2BA90E Q38178818-DFFA2F31-A096-40CC-9961-9C5798C05CB2 Q38192051-29E5ED56-1ED0-4CF7-8C46-79FAD4167DC5 Q38205869-6BB501CB-EEA7-4239-983A-12E107304063 Q38225222-A05AB3C4-47FF-4F18-A8B7-4D3533CAB05B Q38246990-04D19A41-5363-4B39-883D-FE419822FAC2 Q38253145-93AAD4BF-01CE-4713-AFC3-15CEF40BC6CE Q38265958-75D89B57-E69F-4CA7-9EAD-57E8DD0026F6 Q38415724-2B78B967-8B96-48CB-9F4F-8C9E096BB489 Q38462765-8FBE4CAB-0690-4D45-AA46-7377AB6DB6BD Q38543325-941378E6-CEBC-4564-8D77-F83DB96F2E8E Q38601306-6D7B470A-2DA8-4950-A279-0A2D953F2C48 Q38666808-58E4FEED-AE08-4DB1-8AC8-BD396488FDAC Q38777255-860AD23E-87CE-40AA-A87B-5B18C3FF1C58 Q38970533-D970BFA7-8E51-4CA8-820A-9C3B9EAB9030 Q39048706-56AFC562-159C-431F-8340-581A28EBEA96 Q39119181-9FC38243-1350-4EE3-94CA-E58157260738 Q39399454-7F7E9CA5-F27E-45D3-953E-3B3287118F32 Q39435409-CDB389EB-49E9-4ADB-A0F3-65C54DE6758C Q39441592-9E36955E-B808-4D8D-B05F-1837A068CF6F

P2860

Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.

http://www.wikidata.org/entity/Q44144568

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Safety of thiopurines and anti ...... th inflammatory bowel disease.

@en

Safety of thiopurines and anti ...... th inflammatory bowel disease.

@nl

type

label

Safety of thiopurines and anti ...... th inflammatory bowel disease.

@en

Safety of thiopurines and anti ...... th inflammatory bowel disease.

@nl

prefLabel

Safety of thiopurines and anti ...... th inflammatory bowel disease.

@en

Safety of thiopurines and anti ...... th inflammatory bowel disease.

@nl

P1433

Q44144568-23123042-894C-49FB-B9EE-EB559D4FF5D3

P1476

Q44144568-3727F757-6108-44AC-A360-F375078871C3

P2093

Q44144568-0661A618-5DB6-4D63-AE47-599C9400EF0E

Q44144568-13AACABC-E248-418A-909E-8C1A246D5E8E

Q44144568-1459F850-5967-4F50-9DFA-99F4DEDC2DC8

Q44144568-1AD65C8D-6346-49D8-8E00-40C55637413F

Q44144568-1B2330C8-A0F5-4ADE-8EFA-9795CF6422D4

Q44144568-27173EB1-C3D6-434B-9C0D-CB4B515EAB17

Q44144568-2A389198-1182-4911-A440-79E7B23AD1A5

Q44144568-2BC6E4BE-66F2-4F73-8F95-04F9FE61A5E3

Q44144568-2E5D7A4D-ED2C-48CB-87FF-8CBAAD5872D0

Q44144568-3D6E13A1-D34E-484A-AC1D-21134E70475F

P304

Q44144568-0034DB8B-1FE3-4F27-A374-B35E36089544

P31

Q44144568-EB453170-47CE-4CB3-9512-15F6772E0179

P356

Q44144568-253CCBB9-372A-453D-9104-AE256E1B6CF1

P407

Q44144568-DEBFF3BF-5D08-430D-A97C-49E96B574CD2

P433

Q44144568-531BC7BD-45E7-46F8-B1BB-CA2B38609B34

P478

Q44144568-299BF2BD-AAEE-430E-95EA-4E4755D0E936

P50

Q44144568-0520EB28-93CD-4D00-A9B4-C76ECFEBDBA2

Q44144568-375F6821-AC01-4BFB-B4D2-54882192D4FB

Q44144568-52BFDAA4-8404-44A1-A050-E0B3343E966D

Q44144568-57186184-92C6-41E5-9221-5765D1822732

Q44144568-5BA54085-2E7E-45F8-AED8-D3819240E9B0

Q44144568-76F73B5B-7B05-453C-866A-A33089C85DD8

Q44144568-ACE37218-B8B7-445F-AA47-43FEFE3533EA

Q44144568-CB8500A5-199D-4DEB-A35B-DF143B1E2F29

P577

Q44144568-3C9577B4-391F-4CA8-85A0-5E0E9E3948D7

P5875

Q44144568-A78658EE-399A-4503-AD7B-2AE6DEAC8C93

P698

Q44144568-DEF9663D-46AD-40DB-B7BB-2AA7C784876D

P921

Q44144568-0163D831-4A87-42F6-AB75-BA7666F22E51

Q44144568-D03FF601-18A2-4D72-99AF-0F8AEC78452F

P356

P1433

The American Journal of Gastroenterology

P1476

Safety of thiopurines and anti ...... ith inflammatory bowel disease

@en

P2093

A Ponferrada

http://www.w3.org/2001/XMLSchema#string

B Botella

http://www.w3.org/2001/XMLSchema#string

C Dueñas

http://www.w3.org/2001/XMLSchema#string

C Saro

http://www.w3.org/2001/XMLSchema#string

C Taxonera

http://www.w3.org/2001/XMLSchema#string

D Ginard

http://www.w3.org/2001/XMLSchema#string

E Domènech

http://www.w3.org/2001/XMLSchema#string

E García-Planella

http://www.w3.org/2001/XMLSchema#string

E Garrido

http://www.w3.org/2001/XMLSchema#string

E Iglesias

http://www.w3.org/2001/XMLSchema#string

P304

433-440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/AJG.2012.430

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Javier P Gisbert

María Chaparro

Santiago García-López

P577

2013-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234133495

http://www.w3.org/2001/XMLSchema#string

P698

23318480

http://www.w3.org/2001/XMLSchema#string

P921